Taiflex Scientific Co., Ltd. Logo

Taiflex Scientific Co., Ltd.

8039.TW

(2.0)
Stock Price

49,00 TWD

4.93% ROA

8.9% ROE

17.4x PER

Market Cap.

14.813.109.360,00 TWD

20.27% DER

1.64% Yield

7.79% NPM

Taiflex Scientific Co., Ltd. Stock Analysis

Taiflex Scientific Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Taiflex Scientific Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (34%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Dividend

The company's consistent dividend distribution over the past five years reflects its dedication to providing shareholders with steady returns, making it an appealing choice for investors seeking income stability.

3 ROE

The stock's ROE falls within an average range (4.7%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (2.72%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

5 PBV

The stock's PBV ratio (1.11x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

6 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (1.070) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

7 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

9 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

10 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

11 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

Taiflex Scientific Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Taiflex Scientific Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Taiflex Scientific Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Taiflex Scientific Co., Ltd. Revenue
Year Revenue Growth
2009 3.909.099.000
2010 6.859.536.000 43.01%
2011 6.485.299.000 -5.77%
2012 7.853.228.000 17.42%
2013 10.138.227.000 22.54%
2014 10.127.720.000 -0.1%
2015 10.267.868.000 1.36%
2016 10.283.979.000 0.16%
2017 11.192.892.000 8.12%
2018 9.643.051.000 -16.07%
2019 7.583.654.000 -27.16%
2020 8.766.318.000 13.49%
2021 9.405.002.000 6.79%
2022 8.721.875.000 -7.83%
2023 9.948.048.000 12.33%
2023 8.150.519.000 -22.05%
2024 11.522.876.000 29.27%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Taiflex Scientific Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2009 60.740.000
2010 82.407.000 26.29%
2011 86.846.000 5.11%
2012 135.036.000 35.69%
2013 158.711.000 14.92%
2014 189.228.000 16.13%
2015 218.559.000 13.42%
2016 217.559.000 -0.46%
2017 257.468.000 15.5%
2018 264.278.000 2.58%
2019 284.486.000 7.1%
2020 281.360.000 -1.11%
2021 323.220.000 12.95%
2022 400.591.000 19.31%
2023 403.724.000 0.78%
2023 366.518.000 -10.15%
2024 445.896.000 17.8%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Taiflex Scientific Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2009 190.354.000
2010 332.268.000 42.71%
2011 357.745.000 7.12%
2012 345.618.000 -3.51%
2013 432.409.000 20.07%
2014 399.638.000 -8.2%
2015 399.605.000 -0.01%
2016 340.322.000 -17.42%
2017 414.505.000 17.9%
2018 450.461.000 7.98%
2019 361.941.000 -24.46%
2020 344.566.000 -5.04%
2021 424.366.000 18.8%
2022 486.493.000 12.77%
2023 566.600.000 14.14%
2023 478.979.000 -18.29%
2024 588.896.000 18.66%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Taiflex Scientific Co., Ltd. EBITDA
Year EBITDA Growth
2009 683.244.000
2010 1.288.278.000 46.96%
2011 1.108.965.000 -16.17%
2012 1.021.502.000 -8.56%
2013 1.578.038.000 35.27%
2014 1.456.588.000 -8.34%
2015 1.240.727.000 -17.4%
2016 1.078.287.000 -15.06%
2017 1.326.859.000 18.73%
2018 1.102.264.000 -20.38%
2019 1.139.111.000 3.23%
2020 1.313.364.000 13.27%
2021 1.354.154.000 3.01%
2022 1.350.487.000 -0.27%
2023 1.855.176.000 27.2%
2023 976.942.000 -89.9%
2024 1.791.964.000 45.48%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Taiflex Scientific Co., Ltd. Gross Profit
Year Gross Profit Growth
2009 882.874.000
2010 1.665.503.000 46.99%
2011 1.393.386.000 -19.53%
2012 1.563.174.000 10.86%
2013 2.169.550.000 27.95%
2014 2.256.549.000 3.86%
2015 2.164.815.000 -4.24%
2016 1.895.746.000 -14.19%
2017 2.134.577.000 11.19%
2018 1.993.044.000 -7.1%
2019 1.739.138.000 -14.6%
2020 2.078.573.000 16.33%
2021 2.198.643.000 5.46%
2022 2.078.863.000 -5.76%
2023 2.514.680.000 17.33%
2023 1.791.507.000 -40.37%
2024 2.800.468.000 36.03%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Taiflex Scientific Co., Ltd. Net Profit
Year Net Profit Growth
2009 364.250.000
2010 779.890.000 53.29%
2011 562.985.000 -38.53%
2012 620.067.000 9.21%
2013 1.005.346.000 38.32%
2014 882.421.000 -13.93%
2015 729.856.000 -20.9%
2016 579.678.000 -25.91%
2017 734.589.000 21.09%
2018 672.309.000 -9.26%
2019 630.681.000 -6.6%
2020 772.859.000 18.4%
2021 734.654.000 -5.2%
2022 700.483.000 -4.88%
2023 1.106.144.000 36.67%
2023 422.974.000 -161.52%
2024 1.118.892.000 62.2%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Taiflex Scientific Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2009 2
2010 4 66.67%
2011 3 -50%
2012 3 33.33%
2013 5 25%
2014 4 0%
2015 4 -33.33%
2016 3 -50%
2017 4 33.33%
2018 3 0%
2019 3 0%
2020 4 0%
2021 4 0%
2022 3 0%
2023 5 40%
2023 2 -150%
2024 5 50%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Taiflex Scientific Co., Ltd. Free Cashflow
Year Free Cashflow Growth
2009 534.052.000
2010 655.778.000 18.56%
2011 -662.291.000 199.02%
2012 353.673.000 287.26%
2013 422.591.000 16.31%
2014 701.393.000 39.75%
2015 473.857.000 -48.02%
2016 1.025.226.000 53.78%
2017 44.102.000 -2224.67%
2018 -200.661.000 121.98%
2019 1.180.197.000 117%
2020 566.219.000 -108.43%
2021 -313.229.000 280.77%
2022 160.279.000 295.43%
2023 -506.898.000 131.62%
2023 255.485.000 298.41%
2024 -61.040.000 518.55%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Taiflex Scientific Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
2009 599.794.000
2010 1.056.786.000 43.24%
2011 181.385.000 -482.62%
2012 503.657.000 63.99%
2013 880.324.000 42.79%
2014 1.009.220.000 12.77%
2015 971.041.000 -3.93%
2016 1.495.852.000 35.08%
2017 424.401.000 -252.46%
2018 274.120.000 -54.82%
2019 1.993.828.000 86.25%
2020 1.133.063.000 -75.97%
2021 228.233.000 -396.45%
2022 1.141.706.000 80.01%
2023 -216.748.000 626.74%
2023 1.271.852.000 117.04%
2024 148.261.000 -757.85%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Taiflex Scientific Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
2009 65.742.000
2010 401.008.000 83.61%
2011 843.676.000 52.47%
2012 149.984.000 -462.51%
2013 457.733.000 67.23%
2014 307.827.000 -48.7%
2015 497.184.000 38.09%
2016 470.626.000 -5.64%
2017 380.299.000 -23.75%
2018 474.781.000 19.9%
2019 813.631.000 41.65%
2020 566.844.000 -43.54%
2021 541.462.000 -4.69%
2022 981.427.000 44.83%
2023 290.150.000 -238.25%
2023 1.016.367.000 71.45%
2024 209.301.000 -385.6%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Taiflex Scientific Co., Ltd. Equity
Year Equity Growth
2009 3.662.414.000
2010 4.611.600.000 20.58%
2011 5.286.317.000 12.76%
2012 5.564.513.000 5%
2013 6.403.752.000 13.11%
2014 6.755.686.000 5.21%
2015 6.819.277.000 0.93%
2016 6.765.359.000 -0.8%
2017 7.239.063.000 6.54%
2018 7.381.449.000 1.93%
2019 7.352.610.000 -0.39%
2020 7.577.936.000 2.97%
2021 7.913.393.000 4.24%
2022 8.052.075.000 1.72%
2023 8.056.442.000 0.05%
2023 8.068.627.000 0.15%
2024 9.478.082.000 14.87%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Taiflex Scientific Co., Ltd. Assets
Year Assets Growth
2009 5.555.526.000
2010 8.126.029.000 31.63%
2011 8.958.412.000 9.29%
2012 9.373.121.000 4.42%
2013 11.594.780.000 19.16%
2014 12.182.784.000 4.83%
2015 11.878.707.000 -2.56%
2016 11.797.654.000 -0.69%
2017 11.733.236.000 -0.55%
2018 11.941.890.000 1.75%
2019 11.373.981.000 -4.99%
2020 11.531.915.000 1.37%
2021 14.074.880.000 18.07%
2022 12.847.527.000 -9.55%
2023 13.450.005.000 4.48%
2023 13.031.462.000 -3.21%
2024 15.209.325.000 14.32%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Taiflex Scientific Co., Ltd. Liabilities
Year Liabilities Growth
2009 1.893.112.000
2010 3.514.429.000 46.13%
2011 3.672.095.000 4.29%
2012 3.808.608.000 3.58%
2013 5.191.028.000 26.63%
2014 5.427.098.000 4.35%
2015 5.059.430.000 -7.27%
2016 5.032.295.000 -0.54%
2017 4.494.173.000 -11.97%
2018 4.560.441.000 1.45%
2019 4.021.371.000 -13.41%
2020 3.953.979.000 -1.7%
2021 6.161.487.000 35.83%
2022 4.795.452.000 -28.49%
2023 5.393.563.000 11.09%
2023 4.962.835.000 -8.68%
2024 5.731.243.000 13.41%

Taiflex Scientific Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
41.32
Net Income per Share
3.22
Price to Earning Ratio
17.4x
Price To Sales Ratio
1.56x
POCF Ratio
13.36
PFCF Ratio
101.31
Price to Book Ratio
1.37
EV to Sales
1.48
EV Over EBITDA
10.78
EV to Operating CashFlow
14.6
EV to FreeCashFlow
96.48
Earnings Yield
0.06
FreeCashFlow Yield
0.01
Market Cap
14,81 Bil.
Enterprise Value
14,11 Bil.
Graham Number
54.38
Graham NetNet
6.01

Income Statement Metrics

Net Income per Share
3.22
Income Quality
1.2
ROE
0.09
Return On Assets
0.05
Return On Capital Employed
0.08
Net Income per EBT
0.82
EBT Per Ebit
1.09
Ebit per Revenue
0.09
Effective Tax Rate
0.23

Margins

Sales, General, & Administrative to Revenue
0.06
Research & Developement to Revenue
0.04
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.23
Operating Profit Margin
0.09
Pretax Profit Margin
0.09
Net Profit Margin
0.08

Dividends

Dividend Yield
0.02
Dividend Yield %
1.64
Payout Ratio
0.7
Dividend Per Share
0.92

Operating Metrics

Operating Cashflow per Share
4.19
Free CashFlow per Share
0.63
Capex to Operating CashFlow
0.85
Capex to Revenue
0.09
Capex to Depreciation
1.7
Return on Invested Capital
0.06
Return on Tangible Assets
0.05
Days Sales Outstanding
171.93
Days Payables Outstanding
97.25
Days of Inventory on Hand
89.05
Receivables Turnover
2.12
Payables Turnover
3.75
Inventory Turnover
4.1
Capex per Share
3.56

Balance Sheet

Cash per Share
12,42
Book Value per Share
41,12
Tangible Book Value per Share
40.49
Shareholders Equity per Share
40.83
Interest Debt per Share
8.43
Debt to Equity
0.2
Debt to Assets
0.13
Net Debt to EBITDA
-0.54
Current Ratio
1.86
Tangible Asset Value
9,33 Bil.
Net Current Asset Value
3,55 Bil.
Invested Capital
9381347000
Working Capital
4,28 Bil.
Intangibles to Total Assets
0.01
Average Receivables
4,06 Bil.
Average Payables
1,66 Bil.
Average Inventory
1683188000
Debt to Market Cap
0.13

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Taiflex Scientific Co., Ltd. Dividends
Year Dividends Growth
2008 0
2009 1 100%
2010 1 0%
2011 2 100%
2012 2 -100%
2013 1 0%
2014 2 50%
2015 3 0%
2016 2 -100%
2017 2 0%
2018 3 50%
2019 3 0%
2020 1 -100%
2021 3 50%
2022 3 0%
2023 3 0%
2024 1 0%

Taiflex Scientific Co., Ltd. Profile

About Taiflex Scientific Co., Ltd.

Taiflex Scientific Co., Ltd. engages in the manufacture, wholesale, and retail of electronic materials and components in Taiwan. The company offers flexible copper-clad laminate and cover layer; generation and selling of electricity from renewables; and offers FPC materials such as FCCL, coverlay, bonding sheet, stiffener, and composited film for battery, industrial control, automotive applications, comprehensive product specifications, FPC circuit protection, and components. It provides assembly materials. The company was incorporated in 1997 and is headquartered in Kaohsiung, Taiwan.

CEO
Mr. Zong-Han Jiang
Employee
1.239
Address
No. 1, Huanqu 3rd Road
Kaohsiung, 806

Taiflex Scientific Co., Ltd. Executives & BODs

Taiflex Scientific Co., Ltd. Executives & BODs
# Name Age
1 Mr. Jian-Zhi Zhao
Chief Information Security Officer
70
2 Mr. Chi-Yuan Pan
Group Chief Financial Officer & Head of Corporate Governance Officer
70
3 Mr. Chong-Chen Liu
Chief Operating Officer of Global Business & Marketing Center
70
4 Mr. Zong-Han Jiang
Chief Executive Officer & President
70
5 Ms. Fang-I Hsieh
Chief of Staff of the Chairman's Office
70
6 Mr. Fu-Le Lin
Senior R&D Director and Director
70

Taiflex Scientific Co., Ltd. Competitors